Skip to main content
رجوع
VEEV logo

Veeva Systems Inc.

جودة البيانات: 100%
VEEV
NYSE Healthcare Medical - Healthcare Information Services
KWD 179.13
▼ KWD 6.10 (-3.29%)
القيمة السوقية: 29.45B
نطاق اليوم
KWD 176.40 KWD 183.83
نطاق 52 أسبوعًا
KWD 168.14 KWD 310.50
حجم التداول
2,782,254
متوسط 50 يوم / 200 يوم
KWD 196.45 / KWD 254.18
الإغلاق السابق
KWD 185.23

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E 32.4 0.4
P/B 4.1 2.9
ROE % 13.9 3.9
Net Margin % 28.4 3.8
Rev Growth 5Y % 14.6 10.0
D/E 0.0 0.2

السعر المستهدف للمحللين

Hold
KWD 280.100 +56.4%
Low: KWD 205.000 High: KWD 333.000
مكرر الربحية المستقبلي
23.3
ربحية السهم المستقبلية
KWD 7.941
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
3.2 B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2031 KWD 15.295
KWD 15.076 – KWD 15.615
5.9 B 2
FY2030 KWD 13.165
KWD 12.976 – KWD 13.441
5.2 B 1
FY2029 KWD 11.148
KWD 9.770 – KWD 12.654
4.5 B 5

النقاط الرئيسية

Revenue grew 14.63% annually over 5 years — strong growth
Earnings grew 27.27% over the past year
ROE of 13.93% — decent returns on equity
Net margin of 28.44% shows strong profitability
Debt/Equity of 0.01 — conservative balance sheet
Generating 1.39B in free cash flow

النمو

Revenue Growth (5Y)
14.63%
Revenue (1Y)16.34%
Earnings (1Y)27.27%
FCF Growth (3Y)25.14%

الجودة

Return on Equity
13.93%
ROIC9.40%
Net Margin28.44%
Op. Margin28.68%

الأمان

Debt / Equity
0.01
Current Ratio4.89
Interest Coverage0.00

التقييم

P/E Ratio
32.40
P/B Ratio4.08
EV/EBITDA30.69
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 16.34% Revenue Growth (3Y) 16.27%
Earnings Growth (1Y) 27.27% Earnings Growth (3Y) 31.49%
Revenue Growth (5Y) 14.63% Earnings Growth (5Y) 20.76%
Profitability
Revenue (TTM) 3.20B Net Income (TTM) 908.91M
ROE 13.93% ROA 10.12%
Gross Margin 75.53% Operating Margin 28.68%
Net Margin 28.44% Free Cash Flow (TTM) 1.39B
ROIC 9.40% FCF Growth (3Y) 25.14%
Safety
Debt / Equity 0.01 Current Ratio 4.89
Interest Coverage 0.00 Dividend Yield 0.00%
Valuation
P/E Ratio 32.40 P/B Ratio 4.08
P/S Ratio 9.22 PEG Ratio 1.42
EV/EBITDA 30.69 Dividend Yield 0.00%
Market Cap 29.45B Enterprise Value 28.12B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2026 FY2025 FY2024 FY2023 FY2022
Revenue 3.20B 2.75B 2.36B 2.16B 1.85B
Net Income 908.91M 714.14M 525.71M 487.71M 427.39M
EPS (Diluted) 5.44 4.32 3.22 3.00 2.63
Gross Profit 2.41B 2.05B 1.69B 1.55B 1.35B
Operating Income 916.37M 691.44M 429.33M 459.09M 505.50M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2026 FY2025 FY2024 FY2023 FY2022
Total Assets 8.98B 7.34B 5.91B 4.80B 3.82B
Total Liabilities 1.76B 1.51B 1.27B 1.09B 904.83M
Shareholders' Equity 7.21B 5.83B 4.64B 3.72B 2.91B
Total Debt 95.86M 75.78M 55.78M 60.98M 54.59M
Cash & Equivalents 1.42B 1.12B 703.49M 886.47M 1.14B
Current Assets 8.00B 6.31B 5.00B 3.97B 3.11B
Current Liabilities 1.64B 1.40B 1.18B 1.01B 840.78M

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
#866 of 1052
28

النشاط الأخير

دخل Cash Flow Compounder
Mar 24, 2026